Zha Y - Search Results

1

Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma.

Olson DJ, Eroglu Z, Brockstein B, Poklepovic AS, Bajaj M, Babu S, Hallmeyer S, Velasco M, Lutzky J, Higgs E, Bao R, Carll TC, Labadie B, Krausz T, Zha Y, Karrison T, Sondak VK, Gajewski TF, Khushalani NI, Luke JJ. Olson DJ, et al. Among authors: zha y. J Clin Oncol. 2021 Aug 20;39(24):2647-2655. doi: 10.1200/JCO.21.00079. Epub 2021 May 4. J Clin Oncol. 2021. PMID: 33945288 Free PMC article. Clinical Trial.

2

Negative regulation of T-cell function by PD-1.

Zha Yy, Blank C, Gajewski TF. Zha Yy, et al. Crit Rev Immunol. 2004;24(4):229-37. doi: 10.1615/critrevimmunol.v24.i4.10. Crit Rev Immunol. 2004. PMID: 15588223 Review.

3

T cell anergy is reversed by active Ras and is regulated by diacylglycerol kinase-alpha.

Zha Y, Marks R, Ho AW, Peterson AC, Janardhan S, Brown I, Praveen K, Stang S, Stone JC, Gajewski TF. Zha Y, et al. Nat Immunol. 2006 Nov;7(11):1166-73. doi: 10.1038/ni1394. Epub 2006 Oct 8. Nat Immunol. 2006. PMID: 17028589

4

An adenoviral vector encoding dominant negative Cbl lowers the threshold for T cell activation in post-thymic T cells.

Zha Y, Gajewski TF. Zha Y, et al. Cell Immunol. 2007 Jun;247(2):95-102. doi: 10.1016/j.cellimm.2007.07.006. Epub 2007 Sep 25. Cell Immunol. 2007. PMID: 17897636 Free PMC article.

5

Molecular regulation of T-cell anergy.

Zheng Y, Zha Y, Gajewski TF. Zheng Y, et al. Among authors: zha y. EMBO Rep. 2008 Jan;9(1):50-5. doi: 10.1038/sj.embor.7401138. EMBO Rep. 2008. PMID: 18174897 Free PMC article. Review.

6

Use of Cre-adenovirus and CAR transgenic mice for efficient deletion of genes in post-thymic T cells.

Zha Y, Shah R, Locke F, Wong A, Gajewski TF. Zha Y, et al. J Immunol Methods. 2008 Feb 29;331(1-2):94-102. doi: 10.1016/j.jim.2007.11.013. Epub 2007 Dec 26. J Immunol Methods. 2008. PMID: 18177887 Free PMC article.

7

Homeostatic proliferation plus regulatory T-cell depletion promotes potent rejection of B16 melanoma.

Kline J, Brown IE, Zha YY, Blank C, Strickler J, Wouters H, Zhang L, Gajewski TF. Kline J, et al. Clin Cancer Res. 2008 May 15;14(10):3156-67. doi: 10.1158/1078-0432.CCR-07-4696. Clin Cancer Res. 2008. PMID: 18483384

8

Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment.

Harlin H, Meng Y, Peterson AC, Zha Y, Tretiakova M, Slingluff C, McKee M, Gajewski TF. Harlin H, et al. Among authors: zha y. Cancer Res. 2009 Apr 1;69(7):3077-85. doi: 10.1158/0008-5472.CAN-08-2281. Epub 2009 Mar 17. Cancer Res. 2009. PMID: 19293190 Free PMC article.

9

Phase I studies of sirolimus alone or in combination with pharmacokinetic modulators in advanced cancer patients.

Cohen EE, Wu K, Hartford C, Kocherginsky M, Eaton KN, Zha Y, Nallari A, Maitland ML, Fox-Kay K, Moshier K, House L, Ramirez J, Undevia SD, Fleming GF, Gajewski TF, Ratain MJ. Cohen EE, et al. Among authors: zha y. Clin Cancer Res. 2012 Sep 1;18(17):4785-93. doi: 10.1158/1078-0432.CCR-12-0110. Epub 2012 Aug 7. Clin Cancer Res. 2012. PMID: 22872575 Free PMC article. Clinical Trial.

10

Transcriptional regulator early growth response gene 2 (Egr2) is required for T cell anergy in vitro and in vivo.

Zheng Y, Zha Y, Driessens G, Locke F, Gajewski TF. Zheng Y, et al. Among authors: zha y. J Exp Med. 2012 Nov 19;209(12):2157-63. doi: 10.1084/jem.20120342. Epub 2012 Nov 5. J Exp Med. 2012. PMID: 23129747 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

768 results

Search Page